1Guijarro MV, Ghivizzani SC, Gibbs CP. Animal models in osteosar- coma [J]. Frontiers in Oncology, 2014, 4: 189.
2Anninga JK, Gelderblom H, Fiocco M, et al. Chemotherapeutic ad- juvant treatment for osteosarcoma: where do we stand?[J]. Europe- an Journal of Cancer, 2011, 47: 2431-2445.
3Botter SM, Neri D, Fuchs B. Recent advances in osteosarcoma [J]. Current opinion in pharmacology, 2014, 16: 15-23.
8Jaffe N. Historical perspective on the introduction and use of chemo- therapy for the treatment of osteosarcoma [J]. Advances in Experi- mental Medicine and Biology, 2014, 804: 1-30.
9Longhi A, Ferrari S, Bacci G, et al. Long-term follow-up of patients with doxombicin-induced cardiac toxicity after chemotherapy for osteosarcoma [J]. Anti-Cancer Drugs, 2007, 18(6): 737-744.
10Ando K, Mori K, Corradini N, et al. Mifamurtide for the treaanent of nonmetastatic osteosarcoma [J]. Expert Opin Pharmacother, 2011, 12(2): 285-292.
4Rosen G,Mareove RC,Caparros B,et al.Primary osteogenic sarcoma:the rationale for preoperative chemotherapy and delayed surgery.Cancer,1979,43:2163-2177.
5Winkler K,Bielack SS,Delling G,et al.Treatment of osteosarcoma:experience of the Cooperative Osteosarcoma Study Group (COSS).Cancer Treat Res,1993,62:269-277.
6Meyers PA,Heller G,Healey J,et al.Chemotherapy for nonmetastatic osteogenic sarcoma:the Memorial Sloan-Kettering experience.J Clin Oncol,1992,10:5-15.
7Bielack SS,Kempf-Bielack B,Heise U,et al.Combined modality treatment for osteosarcoma occurring as a second malignant disease.Cooperative German-Austrian -Swise Osteosarcoma Study Group.J Clin Oncol,1999,17:1164.
8Goorin AM,Schwartzentruber DJ,Devidas M,et al.Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmctastatic osteosarcoma:Pediatric Oncology Group Study POG-8651.J Clin Oncol,2003,21:1574-1580.
9Huvos A.Pathologic assesment of preoperative (neoadjuvant) chemotherapy//Bone tumors:diagnosis,treatment and prognosis.2nd edition.Philadelphia:WB Saunders,1991:122-128.
10Bielack SS,Kempf-Bielack B,Delling G,et al.Prognostic factors in high-grade osteosarooma of the extremities or trunk:an analysis of1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.J Clin Oncol,2002,20:776-790.
